戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ing the benefits of infliximab in UC-related tracheobronchitis.
2  values of fungal disease (85 ng/mL ATP) and tracheobronchitis (123 ng/mL ATP) had a tendency to be l
3 ally ill patients with ventilator-associated tracheobronchitis, AA decrease VAP and other signs and s
4  Mycoplasma pneumoniae (Mp) infections cause tracheobronchitis and "walking" pneumonia, and are linke
5  included the rates of ventilator-associated tracheobronchitis and acute respiratory distress syndrom
6 ll bacterium without a cell wall that causes tracheobronchitis and atypical pneumonia in humans.
7 nd chronic respiratory infections, including tracheobronchitis and community acquired pneumonia, and
8    Mycoplasma pneumoniae is a major cause of tracheobronchitis and pneumonia in older children and yo
9 less prokaryote Mycoplasma pneumoniae causes tracheobronchitis and primary atypical pneumonia in huma
10 e subglottic stenosis developed pneumococcal tracheobronchitis and subsequently had a localized Herpe
11 atients who were hospitalized for pneumonia, tracheobronchitis, bronchiolitis, croup, exacerbations o
12 st 14 days; and 2) had ventilator-associated tracheobronchitis defined as the production of purulent
13  three patients with nosocomial pneumonia or tracheobronchitis due to multiresistant strains of P. ae
14 een the two groups for ventilator-associated tracheobronchitis: eight patients (10%) in the povidone-
15 ared complication in patients with influenza tracheobronchitis, especially those receiving corticoste
16 ed lung weight and severity of pneumonia and tracheobronchitis in infected W-sh mice.
17        The extra-intestinal manifestation of tracheobronchitis is a rare complication of ulcerative c
18 eumonia; P = 0.857/0.368 and proven/probable tracheobronchitis; P = 0.226/0.529) up to 12 months afte
19 sociated pneumonia and ventilator-associated tracheobronchitis shows promise, but the delivered dose
20 610/3287], followed by ventilator-associated tracheobronchitis (VAT) 10.3% [338/3287].
21  to the development of ventilator-associated tracheobronchitis (VAT) and ventilator-associated pneumo
22 for the development of ventilator-associated tracheobronchitis (VAT) and ventilator-associated pneumo
23                                       Fungal tracheobronchitis was histologically indistinguishable i
24               The incidence of pneumonia and tracheobronchitis was lower, and the duration of stay in
25        Here, we present a case of UC-related tracheobronchitis wherein the positive clinical effects